Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00466440
What this trial is testing

Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Eli Lilly and Company 108
Testing effectiveness (Phase 2)Study completedNCT04011410
What this trial is testing

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
Patrick Hensley 20
Not applicableActive Not RecruitingNCT07126860
What this trial is testing

The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients

Who this might be right for
Prostate CancerMetastatic Prostate CancerProstate Cancer (Post Prostatectomy)+2 more
Ludwig-Maximilians - University of Munich 150
Not applicableStudy completedNCT05127850
What this trial is testing

MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
University of California, San Francisco 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05241860
What this trial is testing

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Who this might be right for
Castration-Sensitive Prostate CarcinomaStage IV Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 79
Not applicableNot Yet RecruitingNCT07591051
What this trial is testing

Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Zurich 54
Testing effectiveness (Phase 2)Study completedNCT03248570
What this trial is testing

Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects

Who this might be right for
Castration Resistant Prostatic CancerMetastatic Prostate Cancer
University of California, San Francisco 26
Early research (Phase 1)Looking for participantsNCT07813637
What this trial is testing

Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC

Who this might be right for
Prostate CancerCastration-Resistant Prostate Cancer (CRPC)Metastatic Prostate Cancer+1 more
Janux Therapeutics 110
Testing effectiveness (Phase 2)Study completedNCT00103337
What this trial is testing

Cilengitide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 106
Not applicableActive Not RecruitingNCT02730338
What this trial is testing

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

Who this might be right for
Metastatic Prostate Cancer
Movember Foundation 866
Not applicableWithdrawnNCT02169063
What this trial is testing

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
University of Washington
Large-scale testing (Phase 3)Study completedNCT00657904
What this trial is testing

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

Who this might be right for
Non-metastatic Prostate Cancer
AstraZeneca 3,618
Testing effectiveness (Phase 2)Ended earlyNCT03360721
What this trial is testing

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma Without Neuroendocrine DifferentiationStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00003614
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00838201
What this trial is testing

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Who this might be right for
CancerCarcinomaCastrate-Resistant Prostate Cancer+2 more
Amgen 384
Testing effectiveness (Phase 2)Study completedNCT02286921
What this trial is testing

Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance

Who this might be right for
Castration Resistant Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 222
Large-scale testing (Phase 3)Looking for participantsNCT04916613
What this trial is testing

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Who this might be right for
Prostate Cancer Metastatic
UNICANCER 300
Testing effectiveness (Phase 2)Study completedNCT03458247
What this trial is testing

Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 94
Testing effectiveness (Phase 2)Study completedNCT00337077
What this trial is testing

Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-refractory Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 121
Testing effectiveness (Phase 2)Ended earlyNCT05553639
What this trial is testing

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Hookipa Biotech GmbH 12
Next Page